This episode transcript covers:
- Alessio’s lab’s ground-breaking research into protein degradation,
- The opening of the University of Dundee’s new Centre for Targeted Protein Degradation (CeTPD)
- The opportunities and challenges of novel degrader design.
To listen to this full podcast episode, click here.
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements